Literature DB >> 8345775

Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast enhanced MRI.

F W Flickinger1, J D Allison, R M Sherry, J C Wright.   

Abstract

Using gadolinium-DTPA enhanced MRI we analyzed the enhancement characteristics of palpable breast masses in 23 patients--10 cancers and 13 benign lesions. The most specific finding for separating benign from malignant lesions was a ratio of maximum intensity change divided by the time interval during which this first occurred. Designated ranges of this ratio were specific for benign disease and sensitive for malignancy in this small patient group. Three of eight fibroadenomas exhibited enhancement patterns indistinguishable from cancer.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8345775     DOI: 10.1016/0730-725x(93)90002-u

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  16 in total

Review 1.  Integration of breast imaging into cancer management.

Authors:  L J Esserman; D Wolverton; N Hylton
Journal:  Curr Oncol Rep       Date:  2000-11       Impact factor: 5.075

2.  Initial clinical experience with contrast-enhanced digital breast tomosynthesis.

Authors:  Sara C Chen; Ann-Katherine Carton; Michael Albert; Emily F Conant; Mitchell D Schnall; Andrew D A Maidment
Journal:  Acad Radiol       Date:  2007-02       Impact factor: 3.173

3.  Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging.

Authors:  Riham H Ei Khouli; Michael A Jacobs; Sarah D Mezban; Peng Huang; Ihab R Kamel; Katarzyna J Macura; David A Bluemke
Journal:  Radiology       Date:  2010-07       Impact factor: 11.105

4.  3-T dynamic contrast-enhanced MRI of the breast: pharmacokinetic parameters versus conventional kinetic curve analysis.

Authors:  Riham H El Khouli; Katarzyna J Macura; Ihab R Kamel; Michael A Jacobs; David A Bluemke
Journal:  AJR Am J Roentgenol       Date:  2011-12       Impact factor: 3.959

5.  Discrimination between benign and malignant breast lesions using volumetric quantitative dynamic contrast-enhanced MR imaging.

Authors:  Ziliang Cheng; Zhuo Wu; Guangzi Shi; Zhilong Yi; Mingwei Xie; Weike Zeng; Chao Song; Chushan Zheng; Jun Shen
Journal:  Eur Radiol       Date:  2017-09-19       Impact factor: 5.315

6.  The relationship between vascular and metabolic characteristics of primary breast tumours.

Authors:  Scott I K Semple; Fiona J Gilbert; Thomas W Redpath; Roger T Staff; Trevor S Ahearn; Andrew E Welch; Steven D Heys; Andrew W Hutcheon; Elizabeth H Smyth; Shailesh Chaturvedi
Journal:  Eur Radiol       Date:  2004-08-14       Impact factor: 5.315

7.  MRI-guided vacuum-assisted breast biopsy: a phantom and patient evaluation of targeting accuracy.

Authors:  Riham H El Khouli; Katarzyna J Macura; Peter B Barker; Laila M Elkady; Michael A Jacobs; Jens Vogel-Claussen; David A Bluemke
Journal:  J Magn Reson Imaging       Date:  2009-08       Impact factor: 4.813

8.  Dynamic contrast-enhanced magnetic resonance imaging for characterising nasopharyngeal carcinoma: comparison of semiquantitative and quantitative parameters and correlation with tumour stage.

Authors:  Bingsheng Huang; Chun-Sing Wong; Brandon Whitcher; Dora Lai-Wan Kwong; Vincent Lai; Queenie Chan; Pek-Lan Khong
Journal:  Eur Radiol       Date:  2013-02-02       Impact factor: 5.315

9.  DCE-MRI parameters have potential to predict response of locally advanced breast cancer patients to neoadjuvant chemotherapy and hyperthermia: a pilot study.

Authors:  Oana I Craciunescu; Kimberly L Blackwell; Ellen L Jones; James R Macfall; Daohai Yu; Zeljko Vujaskovic; Terence Z Wong; Vlayka Liotcheva; Eric L Rosen; Leonard R Prosnitz; Thaddeus V Samulski; Mark W Dewhirst
Journal:  Int J Hyperthermia       Date:  2009       Impact factor: 3.914

10.  Relationship of temporal resolution to diagnostic performance for dynamic contrast enhanced MRI of the breast.

Authors:  Riham H El Khouli; Katarzyna J Macura; Peter B Barker; Mohamed R Habba; Michael A Jacobs; David A Bluemke
Journal:  J Magn Reson Imaging       Date:  2009-11       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.